RSC Advances · 2020 · 25 citations · 28 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryNanomaterialsPharmaceutical FormulationAerosol Particle EngineeringAerosol ScienceDry Powder InhalersInhalation Drug DeliveryNanoparticle DesignNanoparticle FormulationsAerosol Particle DepositionCo-spray DryingDry Powder DepositionMicroparticle FormulationsMicroparticlesNanoparticle Inhalation FormulationsSpray DryingSpray-dried Powders
: this study has successfully produced a lactose-free dry powder formulation containing fluticasone propionate and salmeterol xinafoate with mannitol as excipient engineered as inhalable DPI nanoparticles/microparticles by advanced spray drying. Further, co-spray drying with mannitol and using Handihaler® device can generate higher fine particle mass of fluticasone/salmeterol. Mannitol, a mucolytic agent and aerosol performance enhancer, is a suitable excipient that can enhance aerosol dispersion of DPIs.
28
Surveillance for asthma--United States, 1980-1999.
David M. Mannino, David M. Homa, Lara J. Akinbami et al. · PubMed · 2002 · 1.7K citations · Full text
The public health implications of asthma.
Jean Bousquet, Philippe‐Jean Bousquet, Philippe Godard et al. · PubMed · 2005 · 326 citations
Anthony J. Hickey, Heidi M. Mansour, M Telko et al. · Journal of Pharmaceutical Sciences · 2007 · 158 citations · Full text
Drug Properties Affecting Aerosol Behavior
Anthony J. Hickey · Respiratory Care · 2000 · 122 citations